Avidity Biosciences Inc (RNA)
50.00
-2.55
(-4.85%)
USD |
NASDAQ |
Nov 14, 16:00
49.98
-0.02
(-0.04%)
After-Hours: 16:52
Avidity Biosciences Shareholders Equity (Quarterly): 1.221B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.221B |
| March 31, 2024 | 830.90M |
| December 31, 2023 | 500.76M |
| September 30, 2023 | 517.47M |
| June 30, 2023 | 559.18M |
| March 31, 2023 | 558.92M |
| December 31, 2022 | 578.08M |
| September 30, 2022 | 376.98M |
| June 30, 2022 | 374.35M |
| March 31, 2022 | 375.71M |
| Date | Value |
|---|---|
| December 31, 2021 | 381.43M |
| September 30, 2021 | 394.88M |
| June 30, 2021 | 264.48M |
| March 31, 2021 | 286.12M |
| December 31, 2020 | 306.22M |
| September 30, 2020 | 320.16M |
| June 30, 2020 | 330.30M |
| March 31, 2020 | 66.00M |
| December 31, 2019 | -65.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.36M
Minimum
Dec 2019
1.221B
Maximum
Jun 2024
430.40M
Average
376.98M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 1.221B |
| Natera Inc | 836.52M |
| Entrada Therapeutics Inc | 422.45M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Catalyst Pharmaceuticals Inc | 660.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.347B |
| Total Liabilities (Quarterly) | 126.39M |
| Current Ratio | 15.78 |